Related Experiment Video
Updated: Aug 9, 2026

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
Bleeding update
12nd Division of Gastroenterology, Department of Gastroenterology and Clinical Nutrition, S. Giovanni A.S. Hospital, Via Cavour 31-10123 Torino, Italy. mpen60@yahoo.com
Insights
Capsule endoscopy (CE) is the most efficient first-line diagnostic strategy for obscure bleeding. Proper patient selection and procedure timing maximize diagnostic yield and guide treatment decisions for obscure gastrointestinal bleeding (OGIB).
Area of Science:
- Gastroenterology and Endoscopy
- Medical Diagnostics
Background:
- Obscure gastrointestinal bleeding (OGIB) presents a diagnostic challenge.
- Capsule endoscopy (CE) is increasingly utilized for investigating OGIB.
Purpose of the Study:
- To evaluate the diagnostic efficiency of capsule endoscopy (CE) as a first-line investigation for obscure bleeding.
- To emphasize the importance of patient selection and procedural timing for maximizing diagnostic yield in CE.
- To assess the impact of CE diagnosis on clinical decision-making and patient outcomes in OGIB.
Main Methods:
- Review of existing literature and clinical practice guidelines regarding capsule endoscopy for obscure bleeding.
- Analysis of factors influencing diagnostic yield, including patient selection and procedural timing.
- Evaluation of the role of CE in guiding subsequent investigations and therapeutic strategies.
Main Results:
- Capsule endoscopy (CE) is identified as the most efficient first-line diagnostic strategy for obscure bleeding.
- High diagnostic yield is achievable with careful patient selection and appropriate procedural timing.
- CE diagnosis positively influences clinical outcomes and decision-making for OGIB patients.
Conclusions:
- Capsule endoscopy (CE) is a highly effective tool for diagnosing obscure gastrointestinal bleeding (OGIB) when used as a first-line approach.
- Optimizing patient selection and procedure timing is crucial for maximizing the diagnostic value of CE.
- Further large prospective trials are needed to determine the optimal therapeutic strategies for vascular lesions identified by CE in OGIB patients.
Abstract:
Obscure bleeding is a consolidated indication to CE, which when used as a first-line exploration is the most efficient strategy as regards diagnosis in these patients. Patient selection and timing of the procedure are of paramount importance in the high diagnostic yield of CE. When integrated into a global patient care plan, CE is helpful in achieving effective decision-making concerning subsequent investigations and treatments. Although most studies appear to indicate a positive influence of CE diagnosis on clinical outcome of OGIB patients, large prospective trials are warranted to assess what is the most effective therapeutic strategy in patients with vascular lesions.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
